These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies. Stratton JA; Rettenmaier MA; Phillips HB; Herabutya S; DiSaia PJ Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081 [TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody radioimmunoassay for an antigenic determinant CA125 in ovarian cancer patients. Lian LJ; Hu XF; Liu WS; Wu AJ Chin Med J (Engl); 1986 Sep; 99(9):721-6. PubMed ID: 2433106 [No Abstract] [Full Text] [Related]
4. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors]. Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801 [TBL] [Abstract][Full Text] [Related]
5. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer. Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of CA125 as a circulating tumor marker for ovarian cancer. Kuzuya K; Nozaki M; Chihara T Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):949-57. PubMed ID: 3461071 [TBL] [Abstract][Full Text] [Related]
7. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma. Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181 [TBL] [Abstract][Full Text] [Related]
8. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells. Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184 [TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of specificity of serum CA125 as a tumor marker of ovarian carcinoma]. Iwasaka T; Ohkuma Y; Yoshimura T; Sugimori H Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):917-23. PubMed ID: 2426378 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinomas. Klug TL; Bast RC; Niloff JM; Knapp RC; Zurawski VR Cancer Res; 1984 Mar; 44(3):1048-53. PubMed ID: 6198078 [TBL] [Abstract][Full Text] [Related]
11. Coexpression of different antigenic markers on moieties that bear CA 125 determinants. Yu YH; Schlossman DM; Harrison CL; Rhinehardt-Clark A; Soper JT; Klug TL; Zurawski VR; Bast RC Cancer Res; 1991 Jan; 51(2):468-75. PubMed ID: 1702359 [TBL] [Abstract][Full Text] [Related]
12. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients]. Lian LJ Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787 [No Abstract] [Full Text] [Related]
13. Soluble epidermal growth factor receptor (sEGFR) [corrected] and cancer antigen 125 (CA125) as screening and diagnostic tests for epithelial ovarian cancer. Baron AT; Boardman CH; Lafky JM; Rademaker A; Liu D; Fishman DA; Podratz KC; Maihle NJ Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):306-18. PubMed ID: 15734951 [TBL] [Abstract][Full Text] [Related]
14. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer. Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372 [TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer]. Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320 [TBL] [Abstract][Full Text] [Related]
16. Dissociation in serum CA125 concentrations measured by different monoclonal antibodies. Sakahara H; Kousaka T; Hattori N; Tomida K; Yao Z; Hosono M; Kobayashi H; Shirato M; Endo K; Konishi J Gynecol Oncol; 1994 Mar; 52(3):301-5. PubMed ID: 7512519 [TBL] [Abstract][Full Text] [Related]
17. Hormonal regulation of CA125 tumor marker expression in human ovarian carcinoma cells: inhibition by glucocorticoids. Karlan BY; Amin W; Casper SE; Littlefield BA Cancer Res; 1988 Jun; 48(12):3502-6. PubMed ID: 3285997 [TBL] [Abstract][Full Text] [Related]
18. [The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers]. Suzumori K; Yasui Y; Asai H; Hisaoka T; Mizuno K; Yagami Y Gan No Rinsho; 1985 May; 31(5):544-8. PubMed ID: 3860666 [TBL] [Abstract][Full Text] [Related]
19. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody]. Suzuki H; Teshima K; Noda K Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978 [TBL] [Abstract][Full Text] [Related]
20. [A radioimmunometric assay for circulating tumor-associated glycoprotein (TAG-72) using the antigen determinant CA 72-4]. Ohuchi N; Takahashi K; Matoba N; Mori S Gan To Kagaku Ryoho; 1988 Sep; 15(9):2761-6. PubMed ID: 2458074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]